Verrica Pharmaceuticals Achieves Positive Topline Results in Phase 2 Clinical Study of VP-102 in Patients with Common Warts

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. GOOGL
5. MU
6. USO
7. APGE
8. ABBV
9. MSFT
10. IBM

Go back to Verrica Pharmaceuticals Achieves Positive Topline Results in Phase 2 Clinical Study of VP-102 in Patients with Common Warts

Verrica Pharmaceuticals (VRCA) to Resume Trading at 4:30 pm ET

June 26, 2019 4:14 PM EDT

Verrica Pharmaceuticals (NASDAQ: VRCA) to Resume Trading at 4:30 pm ET

... More